Evidence map›Paper›PMID 28216622›Full record

ArticleActa pharmacologica Sinica2017

Effects of gene polymorphisms in the endoplasmic reticulum stress pathway on clinical outcomes of chemoradiotherapy in Chinese patients with nasopharyngeal carcinoma.

Xiao-Bin Guo, Wan-le Ma, Li-Juan Liu, Yu-Ling Huang, Jing Wang, Li-Hua Huang, Xiang-Dong Peng, Ji-Ye Yin, Jin-Gao Li, Shao-Jun Chen and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Acta pharmacologica Sinica, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.3field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Genetic polymorphisms of CaFrontiers in endocrinology · 2022
    Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 1 country.

Xiao-Bin GuoInner Mongolia Autonomous Region People's Hospital, Hohhot 010017, China.
Wan-le MaCenter of Clinical Pharmacology, Third Xiangya Hospital, Central South University, Changsha 410013, China.
Li-Juan LiuJiangxi Province Tumor Hospital, Nanchang 330029, China.
Yu-Ling HuangJiangxi Province Tumor Hospital, Nanchang 330029, China.
Jing WangJiangxi Province Tumor Hospital, Nanchang 330029, China.
Li-Hua HuangCenter for Medical Experiments, Third Xiangya Hospital, Central South University, Changsha 410013, China.
Xiang-Dong PengDepartment of Pharmacy, Third Xiangya Hospital, Central South University, Changsha 410013, China.
Ji-Ye YinDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, China.
Jin-Gao LiJiangxi Province Tumor Hospital, Nanchang 330029, China.
Shao-Jun ChenDepartment of Oncology, Fourth Affiliated Hospital, Guangxi Medical University, Liuzhou 545005, China.
Guo-Ping YangCenter of Clinical Pharmacology, Third Xiangya Hospital, Central South University, Changsha 410013, China.
Hui WangAffiliated Hunan Provincial Tumor Hospital, Xiangya Medical School, Central South University, Changsha 410013, China.
Cheng-Xian GuoCenter of Clinical Pharmacology, Third Xiangya Hospital, Central South University, Changsha 410013, China.
Jiangxi Provincial Cancer Hospital · CNCentral South University · CNThird Xiangya Hospital · CNFourth Affiliated Hospital of Guangxi Medical University · CNInner Mongolia People's Hospital · CNXiangya Hospital Central South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is considerable inter-individual variabil¬ity in chemoradiotherapy responses in nasopharyngeal carcinoma (NPC) patients receiv¬ing the same or similar treatment protocols. In this study we evaluated the association between the gene polymorphisms in endoplasmic reticulum (ER) stress pathway and chemoradiation responses in Chinese NPC patients. A total of 150 patients with histopathologically conformed NPC and treated with concurrent chemoradiotherapy were enrolled. Genotypes in ER stress pathway genes, including VCP (valosin-containing protein) rs2074549, HSP90B1 rs17034943, CANX (calnexin) rs7566, HSPA5 [heat shock protein family A (Hsp70) member 5] rs430397, CALCR (calcitonin receptor) rs2528521, and XBP1 (X-box binding protein 1) rs2269577 were analyzed by Sequenom MassARRAY system. The short-term effects of primary tumor and lymph node after radiotherapy were assessed based on the Response Evaluation Criteria in Solid Tumors (RECIST) of WHO. And acute radiation-induced toxic reactions were evaluated according to the Radiation Therapy Oncology Group or European Organization for Research and Treatment of Cancer (RTOG/EORTC). The effects of gene polymorphisms on clinical outcomes of chemoradiotherapy were assessed by chi-square test, univariate and multivariate logistic regression analyses. We found that CT and CT+CC genotypes of CANX rs7566 was significantly correlated with primary tumor treatment efficacy at 3 months after chemoradiotherapy and with occurrence of radiation-induced myelosuppression in Chinese NPC patients. CT and CT+CC genotypes of CALCR rs2528521 were significantly correlated with cervical lymph node efficacy at 3 months after chemoradiotherapy. And CC and CT+CC genotypes of VCP rs2074549 were significantly associated with occurrence of myelosuppression. In conclusion, SNPs of VCP rs2074549, CANX rs7566 and CALCR rs2528521 in ER stress pathway genes may serve as predictors for clinical outcomes of chemoradiotherapy in Chinese NPC patients.

Indexed as

Adenosine TriphosphatasesAdultAsian PeopleCalnexinCarcinomaCell Cycle ProteinsChemoradiotherapyEndoplasmic Reticulum Chaperone BiPEndoplasmic Reticulum StressFemaleHumansMaleMiddle AgedNasopharyngeal CarcinomaNasopharyngeal NeoplasmsPolymorphism, GeneticAdenosine TriphosphatasesCalnexinCell Cycle ProteinsEndoplasmic Reticulum Chaperone BiPHSPA5 protein, humanReceptors, CalcitoninValosin Containing ProteinVCP protein, human

Identifiers

PMID28216622
PMCPMC5386314
OpenAlexW2589851059

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.